Advertisement

Topics

As insulin prices rise, endocrinologists confront growing crisis

13:56 EDT 20 Jun 2017 | Healio

The number of Americans with diabetes continues to grow, along with the need for insulin therapy. Between 1997 and 2011, the age-adjusted percentage of adults with diagnosed diabetes prescribed both insulin and other antihyperglycemic agents increased from 9.1% to 13%, with another 17.8% prescribed insulin alone, according to the CDC.Several new insulin therapies are now available or in the pipeline for 2017, including eight basal insulins, six prandial insulins and a “follow-on” product to insulin glargine, Eli Lilly’s Basaglar, approved by the FDA in December 2015.

Original Article: As insulin prices rise, endocrinologists confront growing crisis

NEXT ARTICLE

More From BioPortfolio on "As insulin prices rise, endocrinologists confront growing crisis"

Advertisement
Quick Search
Advertisement
Advertisement